Federal Judge Ordered FDA to Start Reviewing Electronic Cigarettes Present in the U.S. Market

On Wednesday, a federal judge ordered the Food and Drug Administration (FDA) to accelerate its reviews of e-cigs available in the market. The move reveals the support of fed judge for public health groups suing the FDA. In the statement, the district court declares that the agency had side-stepped its legal duty when it delayed analysing all U.S. vaping products from many years. As per the judge, the FDA has knowingly delayed analysing electronic cigarettes contributed to a severe oversight of duty.

Last year, American Academy of Pediatrics, Campaign for Tobacco-Free Kids, and other groups the case in Maryland. The groups claim the FDA that due to its oversight, there’s a massive rise in teenage vaping. Now it is threatening to trap a generation of Americans on nicotine. As per the groups, the FDA should take immediate steps to protect American kids. The lawsuit demands e-cigs producers should receive approval from the FDA if they intend to keep their products in the market. Despite very brief research on its impact on health, many people are adopting a new way to quit cigarettes. Currently, the electronic cigarette market has grown into a multimillion-dollar industry in the U.S.

In 2016, the FDA gained a permit to govern vaping products. The agency has permitted thousands of products without imposing legal rules or product standards. Thus FDA says it will take time to prepare for regulation including both e-cig producers and FDA’s workforce. Paul Grimm, the U.S. Judge, calls the FDA’s delay so intense as to come up to a withdrawal of its statutory duties. Grimm noted that the FDA would have to review the standard rulemaking approaches. The fed judge said manufacturers have to submit their products to the FDA for reviews. On the other hand, Michael Felberbaum, FDA representative, stated that the agency is analysing the court judgement. It will continue to address the alarming outbreak of e-cigarette use among teens.

Show More

Jason Amato

Jason was appointed to a three-year term at in September 2015. Later he was continued as the chief editor of the publication. In his role, Jason serves as the public's representative to He is responsible for bringing transparency to matters of journalism and journalism ethics. receives tens and thousands of inquiries annually and the Jason responds to significant queries, comments, and criticisms. Jason has a decade of experience taking an objective at the media industry and this experience has helped her is expertizing business and health sectors. So, when it's about business and health news, Jason is the go-to guy at

Leave a Reply

Your email address will not be published. Required fields are marked *